BioLineRx Announces Poster Presentation on Apheresis Center Efficiency and CXCR4 Antagonists including APHEXDA(TM) (motixafortide) in Patients with Multiple Myeloma at the ASFA 2024 Annual Meeting
Stockwatch,
BioLineRx Announces Poster Presentation on Apheresis Center Efficiency and CXCR4 Antagonists including APHEXDA® (motixafortide…